Click on the paperclip at the top of the page to add, remove or edit files. If possible, please add a row to the table below to allow easy access to your slides.
...
1/9/14 | LGSR | Joe | Antimicrobial PKPD IDM_clinpharm_Standing_2014.pdf |
8/9/14 meeting starts 2pm | Levinski | Julie | DDMore language |
15/9/14 | LGSR | Paul | Pharmacogenetics of diclofenac |
22/9/14 | LGSR | Yucheng | Count data models and introduction to Pirana |
29/9/14 | LGSR | Andreas | Gabapentin PKPD in paediatric neuropathic pain |
6/10/14 | LGSR | Liana | Tyrosine kinase inhibitor effects in polycystic kindney disease |
13/10/14 | LGSR | Joanna | |
20/10/14 | LGSR | Rollo | Short-term neutrophil and lymphocyte HSCT models |
27/10/14 | LGSR | Eva | NeoGent PKUK practice |
3/11/14 | LGSR | Seb | Item Response Theory: Application to NLME |
10/11/14 | LGSR | Joe | A new mechanistic model for antiretroviral pharmacodynamics |
17/11/14 | LGSR | Alberto | Anaesthesia depth with 3 different EEG measures |
24/11/14 | LGSR | Suzanne Reeves | Mechanisms underpinning antipsychotic sensitivity in Alzheimer's disease |
1/12/14 | LGSR | Deji | Mixed Effect Modelling in Hep C-HIV coinfected children |
8/12/14 meeting starts at 2pm | LGSR | TBC | To be confirmed |
15/12/14 | LGSR | Morris | Understanding the determinants of drug exposure and pharmacokinetic variability in tuberculosis patients |
...
| 7/9/15 | PUW3 | Aiwei | Dexmeditomidine PKPD |
| 14/9/15 | PUW3 | Eva | Meropenem in late onset sepsis and meningitis in neonates |
| 21/9/15 | PUW3 | Ludo | Dexmeditomidine PKPD (in veterinary subjects) |
| 28/9/15 | PUW3 | Ben | Modelling HCMV |
| 5/10/15 | PUW1 | Suzanne | Amisulpride PK update |
| 12/10/15 | PUW1 | David Moore | PKPD in TB |
| 19/10/15 | PUW1 | Joe | Personalised medicine with PKPD |
| 26/10/15 | PUW1 | Imperial Group | Antimicrobial decision support |
| 2/11/15 | PUW1 | ||
| 9/11/15 | PUW2 | Rollo | PhD viva prep talk |
| 16/11/15 | PUW2 | Eva | IRT for neonatal sepsis |
| 23/11/15 | PUW2 | Frank | PKPD in malaria |
| 30/11/15 | PUW2 | Morris | PBPK Modelling in TB |
| 7/12/15 | PUW2 | Liana | PKD PKPD |
| 14/12/15 | PUW2 | Pratima Chowdary | Individualised dosing in haemophilia |
Date
Location* | Presenter | Topic | |
|---|---|---|---|
| 1/2/16 | PUW3 | Deji | HIV models in children |
| 4/4/16 | PUW2 | Morris | Model-based translational research in tuberculosis |
4/7/16 | PUW2 | Albert | SiRNA PD in neuroblastoma |
| 6/2/16 | PUW1 | Charlotte | Update on NAPPA |
6/6/16 | PUW2 | No meeting | PAGE |
| 7/3/16 | PUW3 | Frank | In vitro TB PD |
9/5/16 | PUW3 | Joy Dawes | Morphine and dexmeditomidine PK in children |
| 11/4/16 | PUW3 | Oliver Stirrup | Adult NLME in HIV under HAART |
11/7/16 | PUW2 | No Meeting | To be rescheduled: Min - NAPPA amoxicillin/co-amoxiclav PK results |
13/6/16 | PUW2 | Georgie | Flucloxacillin PK: Neonatal results from NAPPA |
| 14/3/16 | PUW3 | Julie | Bayesian inference in high-throughput pharmacogenetics |
| 15/2/16 | PUW3 | Yucheng | Count data modelling of BATA |
16/5/16 | PUW3 | Julie | Joint modelling of plasmatic and intracellular concentrations of Tenofovir (TDF) and Emtricitabine (FTC) - The COPHAR3 trial |
| 18/1/16 | PUW3 | Planning meeting | |
| 18/4/16 | PUW3 | Ben | Incorporating immunity into CMV models |
20/6/16 | PUW2 | Dan Wright | Model-based dose prediction: the curious case of allopurinol |
| 21/3/16 | PUW2 | Deji | Modelling poor immune response in HIV-infected children |
| 22/2/16 | PUW3 | Ben | CMV model update |
23/5/16 | PUW2 | Letizia | PBPK in TB |
| 25/1/16 | Levinski room | Joe | Scaling in PK and PD |
| 25/4/16 | PUW3 | Per Olsson | Life as a pharmacometrics consultant |
27/6/16 | PUW2 | Salvo | Neonatal antimicrobial PK |
| 29/2/16 | PUW2 | Fabrizia | PKPD in neurology |
...
Date | Location* | Presenter | Topic |
|---|---|---|---|
| 19/12/16 (12:00) | PUW1 | Charlotte | Update on NAPPA |
| 16/1/17 | PUW4 | Frank | Practice MRC interview |
| 23/1/17 | PUW4 | Joe | FLACSAM PK results |
| 30/1/17 | PUW4 | All | Paediatric sample size discussion |
| 6/2/17 | PUW4 | Frank | Update on treosulfan/TB work |
| 13/2/17 | PUW4 | Mike and Sophida | MRes project outline |
| 20/2/17 | PUW2 | Ben | CMV PD |
| 27/2/17 | PUW2 | Charlotte | NAPPA update |
| 6/3/17 | PUW2 | Morris | Rationale for dose selection in tuberculosis: how to scale from mouse to human? |
| 13/3/17 | PUW2 | Benjamin Blaise | iSleep/iCare - real-time metabolic support for personalized intensive care |
| 20/3/17 | PUW2 | ||
| 27/3/17 | PUW2 | Aubrey Cunningham | Adjunctive therapy for severe malaria |
| 3/4/17 | PUW2 | Belen | PhD update |
| 10/4/17 | PUW2 | ||
| 24/4/17 | PUW1 | Annegret Dahlmann-noor | PKPD in ophthalmology |
| 8/5/17 | PUW1 | Paul Baverel | Tralokinumab, an investigational anti-IL13 monoclonal antibody: PK & exposure-response modeling to bridge adult and paediatrics clinical development plan |
| 15/5/17 | PUW1 | Morris | TB modelling PAGE practice |
| 22/5/17 | PUW1 | Ben | CMV modelling ESPID practice |
| 5/6/17 | PUW1 | No meeting | |
| 12/6/17 (12:00) | PUW3 | All | PAGE review |
| 19/6/17 | PUW1 | Ludo | HFIM progress |
| 26/6/17 | PUW1 | Maria Scarpa | End-user acceptability of orodispersible films (ODF) for delivery of medicine |
| 3/7/17 | PUW1 | ||
| 10/7/17 | PUW1 | ||
| 17/7/17 | PUW1 |
...
| 8/1/18 | PUW 4 | planning meeting | |||||
| 15/1/18 | PUW 4 | Haifa | Posaconazole study protocol | ||||
| 22/1/18 | PUW 4 | Frank | Vancomycin PKPD | ||||
| 29/1/18 | PUW 4 | Dagan | Results from ABDose | ||||
| 5/2/18 | PUW 4 | Shan | Salbutamol PKPD | ||||
| 12/2/18 | PUW 4 | Dionna | CoMPLEX mini project | ||||
| 19/2/18 | PUW 3 | ||||||
| 26/2/18 | PUW 3 | Bern | TB-PRACTECAL trial PK-PD study design | ||||
| 5/3/18 | Levinski 12:00 start | Ayesha | Rituximab PKPD | ||||
| 12/3/18 | PUW 3 | Ben | Statistical Challenges in T Cell Receptor Repertoire Immunophenotyping | ||||
| 19/3/18 | PUW 3 | Joe | Posaconazole PK | ||||
| 26/3/18 | PUW 1 | Waty | Machine learning approaches | ||||
| 9/4/18 | PUW 3 | ||||||
| 16/4/18 | PUW 3 | planning meeting | |||||
| 23/4/18 | PUW 3 | no meeting ECCMID | |||||
| 30/4/18 | PUW 3 | Jig | Anticoagulant PKPD in haemodialysis | ||||
| 14/5/18 | PUW 3 | Frank | Modelling progress in TB | ||||
| 21/5/18 | PUW 3 | no meeting PK course | |||||
| 4/6/18 | PUW 3 | Maddlie | PhD introduction: PKPD modelling of sedative and analgesic effects | ||||
| 11/6/18 | PUW 3 | Komal Bhatia | Infant growth in urban informal settlements (slums) in Mumbai, India | ||||
| 18/6/18 | PUW 3 | Shan | Psoriasis PKPD modelling | ||||
| 25/6/18 | PUW 3 | Oleg Volkov | Optimal design in PKPD | ||||
| 2/7/18 | PUW 3 | Ben | CMV modelling | ||||
| 9/7/18 | PUW 3 | Julie | Model-based bioequivalence | ||||
| 3/9/18 | PUW 3 | planning meeting | |||||
| 10/9/18 | PUW3 | Frank | Modelling of in vitro antimicrobial experiments | ||||
| 17/9/18 | PUW3 | no meeting | |||||
| 24/9/18 | PUW3 | Satveer | NIHR practice psoriasis TDM | ||||
| 1/10/18 | PUW1 | Ofran | NIHR practice | ||||
| 8/10/18 | PUW1 | Julie | Dynamic individual predictions of biomarker profiles and survival in Oncology with Stan, Monolix and Nonmem | ||||
| 15/10/18 | PUW1 | ||||||
| 22/10/18 | PUW3 | Rashmi Kulkarni | Monitoring oxidative stress enables predictions of personalised glucose targets in diabetic patients | ||||
| 29/10/18 | PUW3 | ||||||
| 5/11/18 | PUW3 | James Yates | Modelling nonclinical efficacy data for immune-oncology treatments | ||||
| 12/11/18 | PUW3 | Frank | Vancomycin PKPD in children | ||||
| 19/11/18 | PUW1 | John | PhD introduction - nlme in vaccine development | ||||
| 26/11/18 | Levinski | Soumya | PhD introduction | ||||
| 3/12/18 | PUW3 | Jaya | Neonatal vancomycin CSF PK | ||||
| 10/12/18 | PUW3 | Daren Austin | Optimised dose for WHO weight bands | 17/12/18 | PUW3 | Andrew McCallum | Intrapulmonary drug penetration and sputum bacillary elimination in Malawian adults with pulmonary TB |
| 7/1/19 | PUW3 | Planning meeting | |||||
| 14/1/19 | PUW3 | Joe | BSAC Antimicrobial chemotherapy meeting practice | ||||
| 21/1/19 | PUW3 | ||||||
| 28/1/19 | PUW3 | Maddlie | Clonidine/fentanil PK update | ||||
| 4/2/19 | PUW1 | journal club | |||||
| 11/2/19 | PUW1 | Frank | Predicting clinical outcome in TB | ||||
| 18/2/19 | PUW1 | Charlotte | NAPPA overview | ||||
| 25/2/19 | PUW3 | Phil Tresadern | popypkpd introduction | ||||
| 4/3/19 | PUW3 | Silke | PhD work summary | ||||
| 11/3/19 | PUW3 | Ferran | PK paper picking with ML | ||||
| 18/3/19 | PUW3 | Maddlie | PKPD of sedation in neonates | ||||
| 25/3/19 | PUW3 | Jude | PhD Introduction | ||||
| 1/4/19 | PUW1 | Soumya | Rituximab PD in BMT | ||||
| 8/4/19 | LEWINSKY | Zoe | PhD Introduction | ||||
| 15/4/19 | PUW3 | no meeting | ECCMID | ||||
| 13/5/19 | PUW3 | Claire Deakin | Modelling long-term outcomes and estimating treatment efficacy in a rare rheumatic disease | ||||
| 20/5/19 | PUW3 | Haifa | Caspofungin PK in ECMO | ||||
| 3/6/19 | PUW1 | ||||||
| 10/6/19 | LEVINSKY | no meeting | |||||
| 17/6/19 | PUW3 | All | PAGE review | ||||
| 24/6/19 | PUW3 | Cintia | Paediatric Clinical Pharmacology in Buenas Aires | ||||
| 1/7/19 | PUW3 | Wen Yao | PKPd in Malaysia | ||||
| 8/7/19 | PUW3 | Joe | Treo PKPD | ||||
| 15/7/19 | PUW3 | Maddlie | Upgrade practice |